iohexol has been researched along with Carcinoma, Pancreatic Ductal in 7 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Muenzfeld, H | 1 |
| Mahjoub, S | 1 |
| Roehle, R | 1 |
| Pelzer, U | 1 |
| Bahra, M | 1 |
| Boening, G | 1 |
| Hamm, B | 1 |
| Geisel, D | 1 |
| Auer, TA | 1 |
| Ren, S | 1 |
| Zhao, R | 1 |
| Zhang, J | 1 |
| Guo, K | 1 |
| Gu, X | 1 |
| Duan, S | 1 |
| Wang, Z | 1 |
| Chen, R | 1 |
| Garces-Descovich, A | 1 |
| Beker, K | 1 |
| Jaramillo-Cardoso, A | 1 |
| James Moser, A | 1 |
| Mortele, KJ | 1 |
| Seo, N | 1 |
| Byun, JH | 2 |
| Kim, JH | 1 |
| Kim, HJ | 1 |
| Lee, SS | 1 |
| Song, KB | 1 |
| Kim, SC | 1 |
| Han, DJ | 1 |
| Hong, SM | 1 |
| Lee, MG | 2 |
| Hata, H | 1 |
| Mori, H | 1 |
| Matsumoto, S | 1 |
| Yamada, Y | 1 |
| Kiyosue, H | 1 |
| Tanoue, S | 1 |
| Hongo, N | 1 |
| Kashima, K | 1 |
| Li, S | 1 |
| Huang, P | 1 |
| Xu, H | 1 |
| Xu, K | 1 |
| Wu, X | 1 |
| Choi, YJ | 1 |
| Kim, JY | 1 |
| Kim, MH | 1 |
| Jang, SJ | 1 |
| Ha, HK | 1 |
7 other studies available for iohexol and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr | 2019 |
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Fema | 2020 |
Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Computed Tomography An | 2018 |
Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Carcinoma, P | 2016 |
Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT.
Topics: Adenocarcinoma; Aged; Azo Compounds; Carcinoma, Pancreatic Ductal; Coloring Agents; Contrast Media; | 2010 |
Comparison of double contrast-enhanced ultrasound and MDCT for assessing vascular involvement of pancreatic adenocarcinoma: preliminary results correlated with surgical findings.
Topics: Administration, Oral; Aged; Aged, 80 and over; Arteries; Biopsy, Fine-Needle; Carcinoma, Pancreatic | 2012 |
Diffuse pancreatic ductal adenocarcinoma: characteristic imaging features.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retr | 2008 |